SBC Medical Announces the Launch of Non-Invasive Lifting and Skin Improvement Treatment "EMFACE" at NEO Skin Clinic Ginza

Focusing on facial muscles that change with age, aiming for natural lifting and skin quality improvement

IRVINE, Calif. -- SBC Medical Group Holdings Incorporated (Nasdaq: SBC) ("SBC Medical" or the "Company"), a Medical Services Organization providing management support across a wide range of healthcare fields, today announced that NEO Skin Clinic Ginza, a clinic receiving management support from the Company, has commenced offering "EMFACE," a non-invasive treatment that combines HIFES™ (High-Intensity Facial Electrical Stimulation) and Synchronized RF (Radiofrequency) to tighten facial muscles and improve skin quality, effective June 9, 2026.

In recent years, interest in non-invasive treatments that do not involve scalpels has been increasing in aesthetic healthcare. Facial sagging and changes in the facial contour with age are caused not only by a decrease in skin firmness and elasticity, but also by changes in the facial muscles that support the entire face. Against this background, NEO Skin Clinic Ginza has introduced "EMFACE," a treatment device focusing on the facial muscles themselves, in addition to traditional approaches targeting the skin and fat layers. The clinic aims to provide more personalized anti-aging care tailored to each customer's concerns and conditions, including combinations with existing treatments.

EMFACE is a non-invasive lifting and skin quality improvement treatment. HIFES™ stimulates facial muscles to address age-related changes, while Synchronized RF delivers thermal energy to the dermis, supporting the production of collagen and elastin to help maintain and improve skin firmness and elasticity. By targeting both the skin and facial muscles simultaneously, it aims for skin quality improvement and facial line tightening. Because it uses no scalpels or needles, downtime is minimal, and makeup can be applied immediately after the procedure.

Side Effects & Risks: Temporary redness (erythema), warmth, or sensations similar to muscle soreness or fatigue may occur, with individual variations. This treatment is a self-funded procedure and is not covered by public medical insurance.

Comment from Dr. Soichiro Morikawa, Director of NEO Skin Clinic Ginza
"Recently, we have seen an increase in consultations from customers wishing to maintain a youthful impression with changes that are as natural as possible. 'EMFACE' is a treatment that focuses not only on the skin but also on the facial muscles that support the face. We expect it to be a new option, especially for those concerned about mild to moderate sagging and reduced skin elasticity. Furthermore, one of its key features is that it can easily address a wider range of concerns when combined with other device-based treatments or injectables. At our clinic, we will continue to propose tailor-made treatments while closely aligning with each customer's concerns and conditions."

SBC Medical continuously incorporates advanced medical knowledge from both domestic and international sources while promoting the enhancement of knowledge and technical standards through specialized education. In the rapidly evolving field of aesthetic healthcare, the Company thoroughly pursues safety and reproducibility under its own strict verification system, and flexibly introduces new treatments utilizing the latest technology. Moving forward, the Company will continue to strive for safety, transparency, and sustainable value enhancement based on global standards.

About SBC Medical Group Holdings Incorporated
SBC Medical Group Holdings Incorporated is a Medical Services Organization providing management support across a wide range of healthcare fields, including advanced aesthetic healthcare, dermatology, orthopedics, fertility treatment, gynecology, dentistry, alopecia treatment (AGA), and ophthalmology. The Company manages a diverse portfolio of clinic brands and is actively expanding its global presence, particularly in the United States and Asia, through both direct operations and medical tourism initiatives. In September 2024, the Company was listed on Nasdaq, and in June 2025, it was selected for inclusion in the Russell 3000® Index, a broad benchmark of the U.S. equity market. Guided by its Group Purpose "Contributing to the well-being of people around the world through medical innovation," SBC Medical Group Holdings Incorporated continues to provide safe, trusted, and high-quality medical services while further strengthening its international reputation for quality and trust in medical care.

For more information, visit https://sbc-holdings.com
For more insights and updates from SBC Medical, follow us on LinkedIn.

Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking statements are not historical facts or statements of current conditions, but instead represent only the Company's beliefs regarding future events and performance, many of which, by their nature, are inherently uncertain and outside of the Company's control. These forward-looking statements reflect the Company's current views with respect to, among other things, the Company's product launch plans and strategies; growth in revenue and earnings; and business prospects. In some cases, forward-looking statements can be identified by the use of words such as "may," "should," "expects," "anticipates," "contemplates," "estimates," "believes"], "plans," "projected," "predicts," "potential," "targets" or "hopes" or the negative of these or similar terms. The Company cautions readers not to place undue reliance upon any forward-looking statements, which are current only as of the date of this release and are subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. The forward-looking statements are based on management's current expectations and are not guarantees of future performance. The Company does not undertake or accept any obligation to release publicly any updates or revisions to any forward-looking statements to reflect any change in its expectations or any change in events, conditions, or circumstances on which any such statement is based, except as required by law. Factors that may cause actual results to differ materially from current expectations may emerge from time to time, and it is not possible for the Company to predict all of them; such factors include, among other things, changes in global, regional, or local economic, business, competitive, market and regulatory conditions, and those listed under the heading "Risk Factors" and elsewhere in the Company's filings with the U.S. Securities and Exchange Commission (the "SEC"), which are accessible on the SEC's website at www.sec.gov.

Contacts
Hikaru Fukui / Head of IR Department; E-mail: ir@sbc-holdings.com
Akiko Wakiyama / Chief Public Relations Officer; E-mail: pr@sbc.or.jp